$REGN
REGENERON PHARMACEUTICALS, INC.

2020 Q3 Form 10-Q Financial Statement

#000180422020000030 Filed on November 05, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q4 2019 Q3
Revenue $2.294B $1.864B $1.744B
YoY Change 31.56% -3.34% 4.82%
Cost Of Revenue $274.0M $223.9M $225.5M
YoY Change 21.51% 91.04% 104.26%
Gross Profit $2.020B $1.946B $1.518B
YoY Change 33.05% 7.46% -2.25%
Gross Profit Margin 88.06% 104.41% 87.07%
Selling, General & Admin $326.9M $586.8M $304.4M
YoY Change 7.39% 19.44% -17.55%
% of Gross Profit 16.18% 30.16% 20.05%
Research & Development $684.6M $683.1M $526.0M
YoY Change 30.15% 12.67% -5.57%
% of Gross Profit 33.89% 35.11% 34.65%
Depreciation & Amortization $59.30M $54.30M $52.90M
YoY Change 12.1% 26.87% 49.44%
% of Gross Profit 2.94% 2.79% 3.48%
Operating Expenses $1.012B $1.270B $830.4M
YoY Change 21.81% 16.24% -10.34%
Operating Profit $1.053B $675.7M $738.5M
YoY Change 42.6% -5.9% 17.8%
Interest Expense $26.30M $53.20M $7.800M
YoY Change 237.18% -828.77% 5.41%
% of Operating Profit 2.5% 7.87% 1.06%
Other Income/Expense, Net -$54.80M $160.9M $30.00M
YoY Change -282.67% -566.38% 233.33%
Pretax Income $998.3M $889.8M $768.5M
YoY Change 29.9% 31.59% 20.85%
Income Tax $156.2M $97.80M $98.90M
% Of Pretax Income 15.65% 10.99% 12.87%
Net Earnings $842.1M $792.0M $669.6M
YoY Change 25.76% -3.46% 12.59%
Net Earnings / Revenue 36.71% 42.5% 38.4%
Basic Earnings Per Share $7.98 $7.25 $6.12
Diluted Earnings Per Share $7.39 $6.93 $5.86
COMMON SHARES
Basic Shares Outstanding 105.5M shares 109.4M shares
Diluted Shares Outstanding 113.9M shares 114.2M shares

Balance Sheet

Concept 2020 Q3 2019 Q4 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.026B $3.214B $2.878B
YoY Change 5.14% 14.38% 31.3%
Cash & Equivalents $1.573B $1.618B $1.385B
Short-Term Investments $1.453B $1.597B $1.493B
Other Short-Term Assets $785.0M $788.0M $659.0M
YoY Change 19.12% 37.76% 2.33%
Inventory $1.802B $1.416B $1.344B
Prepaid Expenses
Receivables $3.093B $2.100B $2.028B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $9.098B $7.689B $7.109B
YoY Change 27.97% 19.26% 24.29%
LONG-TERM ASSETS
Property, Plant & Equipment $3.138B $2.890B $2.771B
YoY Change 13.24% 12.21% 9.78%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.936B $3.312B $3.113B
YoY Change -5.69% 83.9% 66.12%
Other Assets $168.8M $144.7M $137.9M
YoY Change 22.41% 13.58% 10.15%
Total Long-Term Assets $6.986B $7.116B $6.830B
YoY Change 2.29% 34.6% 34.29%
TOTAL ASSETS
Total Short-Term Assets $9.098B $7.689B $7.109B
Total Long-Term Assets $6.986B $7.116B $6.830B
Total Assets $16.08B $14.81B $13.94B
YoY Change 15.39% 26.17% 29.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $443.0M $418.1M $336.0M
YoY Change 31.85% 91.61% 95.35%
Accrued Expenses $1.303B $1.087B $821.0M
YoY Change 58.71% 40.8% 4.99%
Deferred Revenue $591.7M
YoY Change 30.76%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.338B $2.097B $1.765B
YoY Change 32.42% 45.31% 24.57%
LONG-TERM LIABILITIES
Long-Term Debt $1.978B $0.00 $713.0M
YoY Change 177.46% -100.0% 0.85%
Other Long-Term Liabilities $454.0M $317.7M $273.0M
YoY Change 66.3% -12.16% 40.7%
Total Long-Term Liabilities $2.432B $317.7M $273.0M
YoY Change 790.95% -12.16% 40.7%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.338B $2.097B $1.765B
Total Long-Term Liabilities $2.432B $317.7M $273.0M
Total Liabilities $5.959B $3.716B $3.435B
YoY Change 73.47% 24.8% 16.94%
SHAREHOLDERS EQUITY
Retained Earnings $9.744B $7.380B $6.588B
YoY Change 47.91% 40.45% 48.58%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $6.242B $739.9M $488.4M
YoY Change 1178.05% 86.65% 23.22%
Treasury Stock Shares 15.74M shares 4.860M shares 4.167M shares
Shareholders Equity $10.13B $11.09B $10.50B
YoY Change
Total Liabilities & Shareholders Equity $16.08B $14.81B $13.94B
YoY Change 15.39% 26.17% 29.0%

Cashflow Statement

Concept 2020 Q3 2019 Q4 2019 Q3
OPERATING ACTIVITIES
Net Income $842.1M $792.0M $669.6M
YoY Change 25.76% -3.46% 12.59%
Depreciation, Depletion And Amortization $59.30M $54.30M $52.90M
YoY Change 12.1% 26.87% 49.44%
Cash From Operating Activities -$254.3M $787.4M $557.3M
YoY Change -145.63% 8.04% 23.02%
INVESTING ACTIVITIES
Capital Expenditures -$153.2M -$139.0M -$121.7M
YoY Change 25.88% 62.57% 14.6%
Acquisitions
YoY Change
Other Investing Activities -$622.6M -$69.70M -$85.30M
YoY Change 629.89% -61.36% -52.74%
Cash From Investing Activities -$775.8M -$208.7M -$207.0M
YoY Change 274.78% -21.51% -27.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 612.0M -345.7M -11.00M
YoY Change -5663.64% 316.51% -397.3%
NET CHANGE
Cash From Operating Activities -254.3M 787.4M 557.3M
Cash From Investing Activities -775.8M -208.7M -207.0M
Cash From Financing Activities 612.0M -345.7M -11.00M
Net Change In Cash -418.1M 233.0M 339.3M
YoY Change -223.22% -38.67% 99.59%
FREE CASH FLOW
Cash From Operating Activities -$254.3M $787.4M $557.3M
Capital Expenditures -$153.2M -$139.0M -$121.7M
Free Cash Flow -$101.1M $926.4M $679.0M
YoY Change -114.89% 13.77% 21.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
100500000 USD
dei Entity Central Index Key
EntityCentralIndexKey
0000872589
dei City Area Code
CityAreaCode
914
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-19034
dei Entity Registrant Name
EntityRegistrantName
REGENERON PHARMACEUTICALS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3444607
dei Entity Address Address Line1
EntityAddressAddressLine1
777 Old Saw Mill River Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Tarrytown
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10591-6707
dei Local Phone Number
LocalPhoneNumber
847-7000
dei Security12b Title
Security12bTitle
Common Stock - par value $.001 per share
dei Trading Symbol
TradingSymbol
REGN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1573000000.0 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1617800000 USD
CY2020Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1452900000 USD
CY2019Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1596500000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3092500000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2100000000.0 USD
CY2020Q3 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
460800000 USD
CY2019Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
260600000 USD
CY2020Q3 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
486200000 USD
CY2019Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
425000000.0 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
1801600000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
1415500000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
230600000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
273700000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
9097600000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
7689100000 USD
CY2020Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
2875100000 USD
CY2019Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
3256800000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3138300000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2890400000 USD
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
804200000 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
824200000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
168800000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
144700000 USD
CY2020Q3 us-gaap Assets
Assets
16084000000.0 USD
CY2019Q4 us-gaap Assets
Assets
14805200000 USD
CY2020Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
443100000 USD
CY2019Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
418100000 USD
CY2020Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1303000000.0 USD
CY2019Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1211400000 USD
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
96900000 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
85000000.0 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2337800000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2096600000 USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1978300000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 USD
CY2020Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
716500000 USD
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
713900000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
454000000.0 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
317700000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
5958500000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
3715500000 USD
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6592800000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4428600000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
9743800000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
7379800000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
30800000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
21100000 USD
CY2020Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
15741824 shares
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
4860123 shares
CY2020Q3 us-gaap Treasury Stock Value
TreasuryStockValue
6242000000.0 USD
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
739900000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
10125500000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
11089700000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16084000000.0 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14805200000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2294000000.0 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1743700000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6074200000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4694100000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
684600000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
526000000.0 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1990500000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1897600000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
326900000 USD
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
304400000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1042500000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
890100000 USD
CY2020Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
44600000 USD
CY2019Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
50700000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
135200000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
171100000 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
1240900000 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
1005200000 USD
us-gaap Costs And Expenses
CostsAndExpenses
3664600000 USD
us-gaap Costs And Expenses
CostsAndExpenses
3160000000.0 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1053100000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
738500000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
2409600000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1534100000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-28500000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
37800000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
218300000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
28700000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
26300000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
7800000 USD
us-gaap Interest Expense
InterestExpense
42100000 USD
us-gaap Interest Expense
InterestExpense
23500000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-54800000 USD
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
30000000.0 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
176200000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5200000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
998300000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
768500000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2585800000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1539300000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
156200000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
98900000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
221800000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
215500000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
842100000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
669600000 USD
us-gaap Net Income Loss
NetIncomeLoss
2364000000.0 USD
us-gaap Net Income Loss
NetIncomeLoss
1323800000 USD
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.98
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
21.83
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
12.12
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.39
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.86
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
20.36
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
11.54
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105500000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109400000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
108300000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109200000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113900000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114200000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
116100000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114700000 shares
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
842100000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
669600000 USD
us-gaap Net Income Loss
NetIncomeLoss
2364000000.0 USD
us-gaap Net Income Loss
NetIncomeLoss
1323800000 USD
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4900000 USD
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000000.0 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
10900000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
31500000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
200000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-300000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-1200000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-2700000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
837400000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
670300000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2373700000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1352600000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
11089700000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
817400000 USD
CY2020Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
155100000 USD
CY2020Q1 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
14600000 USD
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
336000000.0 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
108000000.0 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
624600000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-30200000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
12133000000.0 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1355500000 USD
CY2020Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
416500000 USD
CY2020Q2 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
10100000 USD
CY2020Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
5071800000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
105200000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
897300000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
44600000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
9057400000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
297500000 USD
CY2020Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
80900000 USD
CY2020Q3 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
9900000 USD
CY2020Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
100400000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
104600000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
842100000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4700000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
10125500000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
8757300000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
140900000 USD
CY2019Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
10700000 USD
CY2019Q1 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
10500000 USD
CY2019Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
54000000.0 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
114800000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
461100000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
15100000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
9444700000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
13900000 USD
CY2019Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
29700000 USD
CY2019Q2 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
11700000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
109200000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
193100000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
13000000.0 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
9755900000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
8300000 USD
CY2019Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
100000 USD
CY2019Q3 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
6000000.0 USD
CY2019Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
48700000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
0 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
112700000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
669600000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
700000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
10504400000 USD
us-gaap Net Income Loss
NetIncomeLoss
2364000000.0 USD
us-gaap Net Income Loss
NetIncomeLoss
1323800000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
328900000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
174200000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
156000000.0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
310500000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
330800000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
111300000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-113200000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-117900000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
110000000.0 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1275300000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
464500000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
402400000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
227200000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-16400000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-24800000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
112300000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
166800000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
80800000 USD
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-976900000 USD
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
318800000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1387100000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1642600000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
2642700000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
2834900000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
3330300000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1306400000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
453200000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
290600000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
234400000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1819100000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1981900000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
1500000000.0 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
1500000000.0 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2471100000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
163500000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
652500000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
40500000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5465700000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
29400000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1665200000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
93600000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-43700000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-82900000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1630300000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1480200000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1586600000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1397300000 USD
us-gaap Costs And Expenses
CostsAndExpenses
3160000000.0 USD
CY2019Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1211400000 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
85000000.0 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
317700000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1743700000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4694100000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
526000000.0 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1897600000 USD
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
304400000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
890100000 USD
CY2019Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
50700000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
171100000 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
1005200000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
166800000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
328900000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The extent to which the COVID-19 pandemic may directly or indirectly impact our business, financial condition, and results of operations is highly uncertain and subject to change. We considered the potential impact of the COVID-19 pandemic on our estimates and assumptions and there was not a material impact to our condensed consolidated financial statements as of and for the three and nine months ended September 30, 2020; however, actual results could differ from those estimates and there may be changes to our estimates in future periods.</span></div>
regn Maximum Transaction Agreement Payments
MaximumTransactionAgreementPayments
450200000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
842100000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
669600000 USD
us-gaap Net Income Loss
NetIncomeLoss
2364000000.0 USD
us-gaap Net Income Loss
NetIncomeLoss
1323800000 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105500000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109400000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
108300000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109200000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113900000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114200000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
116100000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114700000 shares
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.98
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
21.83
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
12.12
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.39
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.86
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
20.36
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
11.54
CY2020Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
3508300000 USD
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
42900000 USD
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
800000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3550400000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
4206300000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
28500000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
300000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4234500000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1452900000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1596500000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
2097500000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
2638000000.0 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3550400000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4234500000 USD
CY2020Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
606000000.0 USD
CY2020Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
800000 USD
CY2020Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
0 USD
CY2020Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 USD
CY2020Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
606000000.0 USD
CY2020Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
800000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
274500000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
300000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
0 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
274500000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
300000 USD
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
28500000 USD
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 USD
CY2019Q3 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 USD
CY2020Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-37500000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
133800000 USD
CY2019Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
15700000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-58400000 USD
CY2020Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
60600000 USD
CY2019Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
55600000 USD
CY2020Q3 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1929000000 USD
CY2020Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
400400000 USD
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
216300000 USD
CY2020Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
715400000 USD
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
727700000 USD
CY2020Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
132100000 USD
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
70600000 USD
CY2020Q3 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
553700000 USD
CY2019Q4 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
400900000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
1801600000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
1415500000 USD
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.156
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.129
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.086
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.140
CY2020Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
9806805 shares
CY2020Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
5000000000 USD
CY2018 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
54500000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1573000000.0 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1384800000 USD
CY2020Q3 us-gaap Restricted Cash
RestrictedCash
13600000 USD
CY2019Q3 us-gaap Restricted Cash
RestrictedCash
12500000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1586600000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1397300000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
100400000 USD
CY2019 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
133700000 USD
CY2020Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
132200000 USD
CY2019Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
100000000.0 USD

Files In Submission

Name View Source Status
0001804220-20-000030-index-headers.html Edgar Link pending
0001804220-20-000030-index.html Edgar Link pending
0001804220-20-000030.txt Edgar Link pending
0001804220-20-000030-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image_01a.jpg Edgar Link pending
image_11a.jpg Edgar Link pending
image_21a.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
regn-20200930.htm Edgar Link pending
regn-20200930.xsd Edgar Link pending
regn-20200930_cal.xml Edgar Link unprocessable
regn-20200930_def.xml Edgar Link unprocessable
regn-20200930_htm.xml Edgar Link completed
regn-20200930_lab.xml Edgar Link unprocessable
regn-20200930_pre.xml Edgar Link unprocessable
regn-ex101x09302020x10q.htm Edgar Link pending
regn-ex102x09302020x10q.htm Edgar Link pending
regn-ex103x09302020x10q.htm Edgar Link pending
regn-ex311x09302020x10q.htm Edgar Link pending
regn-ex312x09302020x10q.htm Edgar Link pending
regn-ex32x09302020x10q.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending